101 related articles for article (PubMed ID: 11522757)
21. [Adenocarcinoma arising in gastroesophageal junction: a reappraisal].
Zhang XH
Zhonghua Bing Li Xue Za Zhi; 2007 Jun; 36(6):363-5. PubMed ID: 17822618
[No Abstract] [Full Text] [Related]
22. Genetics/genomics/proteomics of gastric adenocarcinoma.
Uppal DS; Powell SM
Gastroenterol Clin North Am; 2013 Jun; 42(2):241-60. PubMed ID: 23639639
[TBL] [Abstract][Full Text] [Related]
23. Single disease entity for both chromosomal instable subtype gastric adenocarcinoma and esophageal adenocarcinoma.
Huang Q
J Dig Dis; 2017 Jun; 18(6):319-322. PubMed ID: 28509354
[TBL] [Abstract][Full Text] [Related]
24. HER2 amplification status in gastric and gastro-oesophageal junction cancer in routine clinical practice: which sample should be used?
Perrone G; Amato M; Callea M; Rabitti C; Righi D; Crucitti P; Coppola R; Onetti Muda A
Histopathology; 2012 Jul; 61(1):134-5. PubMed ID: 22551459
[No Abstract] [Full Text] [Related]
25. Differences in the molecular biology of adenocarcinoma of the esophagus, gastric cardia, and upper gastric third.
Lehmann K; Schneider PM
Recent Results Cancer Res; 2010; 182():65-72. PubMed ID: 20676871
[TBL] [Abstract][Full Text] [Related]
26. ERBB2 amplifications in esophageal adenocarcinoma.
Dahlberg PS; Jacobson BA; Dahal G; Fink JM; Kratzke RA; Maddaus MA; Ferrin LJ
Ann Thorac Surg; 2004 Nov; 78(5):1790-800. PubMed ID: 15511476
[TBL] [Abstract][Full Text] [Related]
27. Oesophageal adenocarcinoma and gastric cancer: should we mind the gap?
Hayakawa Y; Sethi N; Sepulveda AR; Bass AJ; Wang TC
Nat Rev Cancer; 2016 Apr; 16(5):305-18. PubMed ID: 27112208
[TBL] [Abstract][Full Text] [Related]
28. Correlation of hMLH1 and HPP1 hypermethylation in gastric, but not in esophageal and cardiac adenocarcinoma.
Geddert H; Kiel S; Iskender E; Florl AR; Krieg T; Vossen S; Gabbert HE; Sarbia M
Int J Cancer; 2004 Jun; 110(2):208-11. PubMed ID: 15069683
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in gastric and colorectal adenocarcinoma.
Zhang Y; Ye X; Geng J; Chen L
Hepatogastroenterology; 2010; 57(104):1614-9. PubMed ID: 21443130
[TBL] [Abstract][Full Text] [Related]
30. 11p13-15 is a specific region of chromosomal rearrangement in gastric and esophageal adenocarcinomas.
Rodriguez E; Rao PH; Ladanyi M; Altorki N; Albino AP; Kelsen DP; Jhanwar SC; Chaganti RS
Cancer Res; 1990 Oct; 50(19):6410-6. PubMed ID: 2400998
[TBL] [Abstract][Full Text] [Related]
31. Hypermethylation of tumor suppressor genes (p16INK4A, p14ARF and APC) in adenocarcinomas of the upper gastrointestinal tract.
Sarbia M; Geddert H; Klump B; Kiel S; Iskender E; Gabbert HE
Int J Cancer; 2004 Aug; 111(2):224-8. PubMed ID: 15197775
[TBL] [Abstract][Full Text] [Related]
32. Chromosomal imbalances in gastric and esophageal adenocarcinoma: specific comparative genomic hybridization-detected abnormalities segregate with junctional adenocarcinomas.
Stocks SC; Pratt N; Sales M; Johnston DA; Thompson AM; Carey FA; Kernohan NM
Genes Chromosomes Cancer; 2001 Sep; 32(1):50-8. PubMed ID: 11477661
[TBL] [Abstract][Full Text] [Related]
33. Definitions of oesophageal cancer.
Burki TK
Lancet Oncol; 2017 Feb; 18(2):e71. PubMed ID: 28089633
[No Abstract] [Full Text] [Related]
34. CpG island hypermethylation in progression of esophageal and gastric cancer.
Sato F; Meltzer SJ
Cancer; 2006 Feb; 106(3):483-93. PubMed ID: 16362978
[TBL] [Abstract][Full Text] [Related]
35. [Inherent mdr-1 gene expression in fresh tumor tissue specimens from several high-incidence malignancies].
Yin L; Chen K; Li D
Zhonghua Zhong Liu Za Zhi; 1997 Nov; 19(6):420-2. PubMed ID: 10920872
[TBL] [Abstract][Full Text] [Related]
36. [Leiomyosarcoma of the oesophagus and gastric adenocarcinoma with family history of HNPCC syndrome].
Köhler K; Stelzner S; Haroske G; Witzigmann H
Zentralbl Chir; 2011 Jun; 136(3):284-8. PubMed ID: 21049402
[No Abstract] [Full Text] [Related]
37. [Detection and significance of epidermal growth factor receptor mutation in esophageal, esophagogastric junction and gastric cancers].
Lyu X; Huang J; Liu J; Wang W; Su Y; Zhang W; Sun Y; Ying J; Wang J; Sun Y
Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):346-50. PubMed ID: 25030589
[TBL] [Abstract][Full Text] [Related]
38. Oncogene activation in esophageal cancer.
Casson AG; Mukhopadhyay T; Cleary KR; Ro JY; Levin B; Roth JA
J Thorac Cardiovasc Surg; 1991 Nov; 102(5):707-9. PubMed ID: 1943188
[TBL] [Abstract][Full Text] [Related]
39. First comprehensive guideline released for the assessment of HER2 in patients with GEA.
Washington MK
MLO Med Lab Obs; 2017 Mar; 49(3):30-1. PubMed ID: 29924569
[No Abstract] [Full Text] [Related]
40. A tumor-suppressive role for trypsin in human cancer progression.
Yamashita K; Mimori K; Inoue H; Mori M; Sidransky D
Cancer Res; 2003 Oct; 63(20):6575-8. PubMed ID: 14583448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
